---
layout: post
title: "Prospective Grant of an Exclusive Patent License: Development, Production, and Commercialization of a Seasonal Influenza Vaccine"
date: 2026-02-05 19:09:35 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-08879
original_published: 2020-04-27 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: Development, Production, and Commercialization of a Seasonal Influenza Vaccine

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 27, 2020 00:00 UTC
**Document Number:** 2020-08879

## Summary

The U.S. Food and Drug Administration (FDA) is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the SUPPLEMENTARY INFORMATION section of this notice to Sciogen Inc. located in San Jose, California.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/04/27/2020-08879/prospective-grant-of-an-exclusive-patent-license-development-production-and-commercialization-of-a)
- API: https://www.federalregister.gov/api/v1/documents/2020-08879

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
